Sato Pharmaceutical Co., Ltd. is recalling 3,640 bottles of INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide, and simethicone) because the tablets failed to break down (disintegrate) within the expected timeframe. This issue affects 75-count bottles from lot PWXT that were distributed in California and Hawaii. Because the tablets do not dissolve as intended, they may not provide the expected relief for digestive symptoms.
The tablets do not break down properly in the digestive tract, which means the active ingredients may not be released effectively, potentially resulting in a lack of treatment for the consumer's symptoms.
You have 2 options:
Recall #: D-0298-2026
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.